These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 11402748)

  • 21. Assessment of the vasodilator response in primary pulmonary hypertension. Comparing prostacyclin and iloprost administered by either infusion or inhalation.
    Opitz CF; Wensel R; Bettmann M; Schaffarczyk R; Linscheid M; Hetzer R; Ewert R
    Eur Heart J; 2003 Feb; 24(4):356-65. PubMed ID: 12581683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute and long-term effects of inhaled iloprost in portopulmonary hypertension.
    Melgosa MT; Ricci GL; García-Pagan JC; Blanco I; Escribano P; Abraldes JG; Roca J; Bosch J; Barberà JA
    Liver Transpl; 2010 Mar; 16(3):348-56. PubMed ID: 20209595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhaled iloprost controls pulmonary hypertension after cardiopulmonary bypass.
    Theodoraki K; Rellia P; Thanopoulos A; Tsourelis L; Zarkalis D; Sfyrakis P; Antoniou T
    Can J Anaesth; 2002 Nov; 49(9):963-7. PubMed ID: 12419726
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiremodeling effects of iloprost and the dual-selective phosphodiesterase 3/4 inhibitor tolafentrine in chronic experimental pulmonary hypertension.
    Schermuly RT; Kreisselmeier KP; Ghofrani HA; Samidurai A; Pullamsetti S; Weissmann N; Schudt C; Ermert L; Seeger W; Grimminger F
    Circ Res; 2004 Apr; 94(8):1101-8. PubMed ID: 15031263
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhaled nitric oxide versus aerosolized iloprost for the treatment of pulmonary hypertension with left heart disease.
    Yin N; Kaestle S; Yin J; Hentschel T; Pries AR; Kuppe H; Kuebler WM
    Crit Care Med; 2009 Mar; 37(3):980-6. PubMed ID: 19237907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhaled iloprost in eight heart transplant recipients presenting with post-bypass acute right ventricular dysfunction.
    Theodoraki K; Tsiapras D; Tsourelis L; Zarkalis D; Sfirakis P; Kapetanakis E; Alivizatos P; Antoniou T
    Acta Anaesthesiol Scand; 2006 Nov; 50(10):1213-7. PubMed ID: 16978158
    [TBL] [Abstract][Full Text] [Related]  

  • 27. First experiences with the stable prostacyclin analog iloprost in the evaluation of heart transplant candidates with increased pulmonary vascular resistance.
    Sablotzki A; Czeslick E; Gruenig E; Friedrich I; Schubert S; Börgermann J; Hentschel T
    J Thorac Cardiovasc Surg; 2003 Apr; 125(4):960-2. PubMed ID: 12698166
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical efficacy and survival with first-line inhaled iloprost therapy in patients with idiopathic pulmonary arterial hypertension.
    Opitz CF; Wensel R; Winkler J; Halank M; Bruch L; Kleber FX; Höffken G; Anker SD; Negassa A; Felix SB; Hetzer R; Ewert R
    Eur Heart J; 2005 Sep; 26(18):1895-902. PubMed ID: 15888496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aerosolized iloprost for pulmonary vasoreactivity testing in children with long-standing pulmonary hypertension related to congenital heart disease.
    Limsuwan A; Khosithseth A; Wanichkul S; Khowsathit P
    Catheter Cardiovasc Interv; 2009 Jan; 73(1):98-104. PubMed ID: 19089967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sildenafil improves dynamic vascular function in the brain: studies in patients with pulmonary hypertension.
    Rosengarten B; Schermuly RT; Voswinckel R; Kohstall MG; Olschewski H; Weissmann N; Seeger W; Kaps M; Grimminger F; Ghofrani HA
    Cerebrovasc Dis; 2006; 21(3):194-200. PubMed ID: 16388195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension.
    Michelakis ED; Tymchak W; Noga M; Webster L; Wu XC; Lien D; Wang SH; Modry D; Archer SL
    Circulation; 2003 Oct; 108(17):2066-9. PubMed ID: 14568893
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute hemodynamic responses to adenosine and iloprost in patients with congenital heart defects and severe pulmonary arterial hypertension.
    Zhang DZ; Zhu XY; Meng J; Xue HM; Sheng XT; Han XM; Cui CS; Wang QG; Zhang P
    Int J Cardiol; 2011 Mar; 147(3):433-7. PubMed ID: 20537740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemodynamic effects of aerosolized iloprost in pulmonary hypertension at rest and during exercise.
    Blumberg FC; Riegger GA; Pfeifer M
    Chest; 2002 May; 121(5):1566-71. PubMed ID: 12006445
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhalative iloprost - pharmacology and clinical application.
    Ewert R; Schäper C; Halank M; Gläser S; Opitz CF
    Expert Opin Pharmacother; 2009 Sep; 10(13):2195-207. PubMed ID: 19663611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of iloprost inhalation on exercise capacity and ventilatory efficiency in patients with primary pulmonary hypertension.
    Wensel R; Opitz CF; Ewert R; Bruch L; Kleber FX
    Circulation; 2000 May; 101(20):2388-92. PubMed ID: 10821815
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination therapy of prostacyclin for pulmonary hypertension in congenital heart disease.
    Durongpisitkul K; Jakrapanichakul D; Laohaprasitiporn D; Soongswang J; Chanthong P; Nana A
    J Med Assoc Thai; 2005 Nov; 88 Suppl 8():S60-5. PubMed ID: 16856428
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension. German PPH study group.
    Hoeper MM; Olschewski H; Ghofrani HA; Wilkens H; Winkler J; Borst MM; Niedermeyer J; Fabel H; Seeger W
    J Am Coll Cardiol; 2000 Jan; 35(1):176-82. PubMed ID: 10636277
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute responses to inhalation of Iloprost in patients with pulmonary hypertension.
    Zhang HL; Liu ZH; Wang Y; Xiong CM; Ni XH; He JG; Luo Q; Zhao ZH; Zhao Q; Sun XG
    Chin Med J (Engl); 2012 Aug; 125(16):2826-31. PubMed ID: 22932074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Iloprost for pulmonary vasodilator testing in idiopathic pulmonary arterial hypertension.
    Jing ZC; Jiang X; Han ZY; Xu XQ; Wang Y; Wu Y; Lv H; Ma CR; Yang YJ; Pu JL
    Eur Respir J; 2009 Jun; 33(6):1354-60. PubMed ID: 19213781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ultrasonic versus jet nebulization of iloprost in severe pulmonary hypertension.
    Gessler T; Schmehl T; Hoeper MM; Rose F; Ghofrani HA; Olschewski H; Grimminger F; Seeger W
    Eur Respir J; 2001 Jan; 17(1):14-9. PubMed ID: 11307743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.